Skip to ContentSkip to Navigation
About us Practical matters How to find us prof. dr. H.J. (Henkjan) Verkade

Publications

Absence of Pupillary Reflexes in Pediatric Acute Liver Failure and Neurological Outcome After Liver Transplantation

De gele baby

Genome-wide meta-analysis associates donor-recipient non-HLA genetic mismatch with acute cellular rejection post-liver transplantation

Molecular adsorbent recirculating system (MARS®) and continuous renal replacement therapy for the treatment of paediatric acute liver failure: two-centre retrospective cohort study

Obtaining first-line induction in autoimmune hepatitis: Aren't we underestimating prednisolone?

Sleep duration among breastfed, goat milk-based or cow's milk-based infant formula-fed infants: Post hoc analyses from a double-blind RCT

EASL Clinical Practice Guidelines on genetic cholestatic liver diseases

Efficacy and safety of odevixibat in patients with Alagille syndrome (ASSERT): a phase 3, double-blind, randomised, placebo-controlled trial

Emerging drugs for the treatment of progressive familial intrahepatic cholestasis: a focus on phase II and III trials

Event-free survival of maralixibat-treated patients with Alagille syndrome compared to a real-world cohort from GALA

Press/media

Waarom Nederlandse baby’s geen vitamine K-prik krijgen (terwijl die levens kan redden)

Drugs, approval in the EU of 2 new therapies for rare cholestatic diseases

Ipsen crosses EU finish line with Alagille syndrome drug

Ipsen’s Kayfanda® Approved in European Union for Rare Liver Disease

Malattie colestatiche rare: il CHMP esprime parere positivo su due nuove molecole

Ipsen: parere positivo del Chmp su due farmaci per malattie epatiche rare